City State Bank - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 167 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
City State Bank ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$5
+25.0%
1000.0%0.00%
+50.0%
Q1 2023$4
+33.3%
1000.0%0.00%0.0%
Q4 2022$3
-99.8%
1000.0%0.00%
+100.0%
Q3 2022$2,000
-33.3%
1000.0%0.00%
-50.0%
Q2 2022$3,000
-40.0%
100
-33.3%
0.00%
-33.3%
Q1 2022$5,000
+66.7%
1500.0%0.00%
+50.0%
Q4 2021$3,0001500.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders